• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Egypt Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012 Product Image

Egypt Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012

  • Published: December 2008
  • Region: Egypt
  • 184 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • Cordis Corporation
  • Medtronic, Inc.
  • St. Jude Medical Inc.
  • Terumo Corporation
  • MORE

Egypt Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Egypt cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices in Egypt

Scope

- The report provides cardiovascular devices market information broken down into detailed categories and segments in Egypt.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions READ MORE >

1 2
1.1 List of Tables 9
1.2 List of Figures 13
2 Introduction 16
2.1 What Is This Report About? 16
3 Definitions of Markets Covered in the Report 17
3.1 Cardiovascular Devices 17
3.1.1 Pacemakers 17
3.1.2 Implantable Cardioverter Defibrillator (ICD) 17
3.1.3 Cardiac Resynchronisation Therapy 17
3.2 Interventional Cardiology 17
3.2.1 Coronary Stents 17
3.2.2 Cardiac Catheters 18
3.2.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters 18
3.3 Peripheral Vascular Devices 19
3.3.1 Peripheral Vascular Stents 19
3.3.2 Inferior Vena Cava Filter 19
3.3.3 PTA Balloon 19
3.3.4 Aortic Stent Graft 19
3.4 Cardiovascular Surgery 19
3.4.1 Beating Heart Systems 19
3.4.2 Cardiac Ablation Devices 20
3.4.3 Perfusion Systems 20
3.5 Cardiovascular Prosthetic Device 20
3.5.1 Prosthetic heart valves 20
3.5.2 Cardiac Assist Devices 20
3.6 Cardiovascular Monitoring and Diagnostic Devices 21
3.6.1 ECG Monitoring Equipment 21
3.6.2 ECG Stress Testing Systems 21
3.6.3 Holter Monitoring Systems 21
3.6.4 Event Monitoring Systems 21
4 Healthcare Sector Review 22
5 Regulation System 23
5.1 Approval Process 23
5.2 Registration Procedures 24
5.3 Registration of Class I, Class IIa and Class IIb devices at DPPC 24
5.4 Declaration of Conformity (Self certification) 25
5.5 Free Sale Certificate 25
5.6 CE Certificate 26
6 Pricing and Reimbursement 27
7 Distribution Structure 28
8 Cardiovascular Devices In Egypt 29
8.1 Cardiovascular Devices Cross Country Comparison (2000-2012) 29
8.2 Cardiovascular Devices, Egypt, Overall Revenues ($ mn), 2000-2012 30
8.3 Cardiovascular Devices, Egypt, Category Volume (Units), 2000-2012 36
8.4 Cardiovascular Devices, Egypt, Company Share (2006-2007) 41
9 Cardiac Rhythm Management In Egypt 42
9.1 Cardiac Rhythm Management Overall Revenue (2000-2012) 42
9.1.1 Cardiac Resynchronisation Therapy Overall Revenues (2000-2012) 44
9.1.2 Implantable Cardioverter Defibrillator Overall Revenues (2000-2012) 46
9.1.3 Pacemaker Overall Revenues (2000-2012) 48
9.2 Cardiac Rhythm Management Overall Volume (2000-2012) 50
9.2.1 Cardiac Resynchronisation Therapy Overall Volume (2000-2012) 52
9.2.2 Implantable Cardioverter Defibrillator Overall Volume (2000-2012) 54
9.2.3 Pacemaker Overall Volume (2000-2012) 56
9.3 Cardiac Rhythm Management Average Price (2000-2012) 58
9.4 Cardiac Rhythm Management Distribution Share (2006-2007) 59
9.5 Cardiac Rhythm Management, Egypt, Company Share (2006-2007) 60
10 Cardiovascular Monitoring and Diagnostic Devices In Egypt 61
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2012) 61
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2012) 65
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2012) 67
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2006-2007) 68
10.5 Cardiovascular Monitoring and Diagnostic Devices, Egypt, Company Share (2006-2007) 69
11 Cardiovascular Prosthetic Devices In Egypt 70
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2012) 70
11.1.1 Cardiac Assist Devices Overall Revenues (2000-2012) 73
11.1.2 Prosthetic Heart Valve Overall Revenues (2000-2012) 75
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2012) 77
11.2.1 Cardiac Assist Devices Overall Volume (2000-2012) 79
11.2.2 Prosthetic Heart Valve Overall Volume (2000-2012) 81
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2012) 83
11.4 Cardiovascular Prosthetic Devices Distribution Share (2006-2007) 84
11.5 Cardiovascular Prosthetic Devices, Egypt, Company Share (2006-2007) 85
12 Cardiovascular Surgery In Egypt 86
12.1 Cardiovascular Surgery Overall Revenue (2000-2012) 86
12.1.1 Perfusion Disposables Overall Revenues (2000-2012) 89
12.2 Cardiovascular Surgery Overall Volume (2000-2012) 91
12.2.1 Perfusion Disposables Overall Volume (2000-2012) 92
12.3 Cardiovascular Surgery Average Price (2000-2012) 94
12.4 Cardiovascular Surgery Distribution Share (2006-2007) 95
12.5 Cardiovascular Surgery, Egypt, Company Share (2006-2007) 96
13 Electrophysiology In Egypt 97
13.1 Electrophysiology Overall Revenue (2000-2012) 97
13.2 Electrophysiology Overall Volume (2000-2012) 99
13.3 Electrophysiology Average Price (2000-2012) 100
13.4 Electrophysiology Distribution Share (2006-2007) 101
13.5 Electrophysiology, Egypt, Company Share (2006-2007) 102
14 Interventional Cardiology In Egypt 103
14.1 Interventional Cardiology Overall Revenue (2000-2012) 103
14.1.1 Cardiac Catheter Overall Revenues (2000-2012) 107
14.1.2 Coronary Stent Overall Revenues (2000-2012) 109
14.1.3 PTCA Balloon Overall Revenues (2000-2012) 111
14.2 Interventional Cardiology Overall Volume (2000-2012) 113
14.2.1 Cardiac Catheter Overall Volume (2000-2012) 117
14.2.2 Coronary Stent Overall Volume (2000-2012) 119
14.2.3 PTCA Balloon Overall Volume (2000-2012) 121
14.3 Interventional Cardiology Average Price (2000-2012) 123
14.4 Interventional Cardiology Distribution Share (2006-2007) 125
14.5 Interventional Cardiology, Egypt, Company Share (2006-2007) 126
15 Peripheral Vascular Devices In Egypt 127
15.1 Peripheral Vascular Devices Overall Revenue (2000-2012) 127
15.2 Peripheral Vascular Devices Overall Volume (2000-2012) 131
15.3 Peripheral Vascular Devices Average Price (2000-2012) 135
15.4 Peripheral Vascular Devices Distribution Share (2006-2007) 136
15.5 Peripheral Vascular Devices, Egypt, Company Share (2006-2007) 137
16 Medtronic, Inc. Company Profile 138
16.1 Company Overview 138
16.2 Value Chain Analysis 139
16.2.1 Manufacturing 140
16.2.2 Product Development 140
16.2.3 Sales and Marketing 140
16.3 Medtronic, Inc. Pipeline Products 141
16.3.1 Medtronic, Inc. Pipeline Products By Equipment Type 141
16.3.2 Medtronic, Inc. Pipeline Products by Development Stage 143
16.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 145
16.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 147
16.3.5 Medtronic, Inc. Pipeline Products by News Summary 148
17 Boston Scientific Corporation Company Profile 149
17.1 Company Overview 149
17.2 Value Chain Analysis 149
17.2.1 Manufacturing 150
17.2.2 Product Development 150
17.2.3 Sales and Marketing 151
17.3 Boston Scientific Corporation Pipeline Products 151
17.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type 151
17.3.2 Boston Scientific Corporation Pipeline Products by Development Stage 153
17.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 154
17.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 155
17.3.5 Boston Scientific Corporation Pipeline Products by News Summary 156
18 Cordis Corporation Company Profile 158
18.1 Company Overview 158
18.2 Cordis Corporation Pipeline Products 159
18.2.1 Cordis Corporation Pipeline Products by Equipment Type 159
18.2.2 Cordis Corporation Pipeline Products by Development Stage 159
18.2.3 Cordis Corporation Pipeline Products by Therapy Area 160
18.2.4 Cordis Corporation Pipeline Products by Clinical Trials 160
18.2.5 Cordis Corporation Pipeline Products by News Summary 160
19 St. Jude Medical Inc. Company Profile 161
19.1 Company Overview 161
19.2 Value Chain Analysis 162
19.2.1 Manufacturing 163
19.2.2 Product Development 163
19.2.3 Sales and Marketing 164
19.3 St. Jude Medical Inc. Pipeline Products 165
19.3.1 St. Jude Medical Inc. Pipeline Products by Equipment Type 165
19.3.2 St. Jude Medical Inc. Pipeline Products by Development Stage 166
19.3.3 St. Jude Medical Inc. Pipeline Products by Therapy Area 167
19.3.4 St. Jude Medical Inc. Pipeline Products by Clinical Trials 167
19.3.5 St. Jude Medical Inc. Pipeline Products by News Summary 168
20 Abbott Laboratories Company Profile 169
20.1 Company Overview 169
20.2 Value Chain Analysis 170
20.2.1 Manufacturing 171
20.2.2 Product Development 171
20.2.3 Sales and Marketing 172
20.2.4 Abbott Laboratories Pipeline Products by Equipment Type 172
20.2.5 Abbott Laboratories Pipeline Products by Development Stage 173
20.2.6 Abbott Laboratories Pipeline Products by Therapy Area 173
20.2.7 Abbott Laboratories Pipeline Products by Clinical Trials 173
20.2.8 Abbott Laboratories Pipeline Products by News Summary 173
21 Terumo Corporation Company Profile 174
21.1 Company Overview 174
21.2 Value Chain Analysis 174
21.2.1 Manufacturing 175
21.2.2 Product Development 175
21.2.3 Sales and Marketing 175
21.3 Terumo Corporation Pipeline Products 176
21.3.1 Terumo Corporation Pipeline Products by Equipment Type 176
21.3.2 Terumo Corporation Pipeline Products by Development Stage 176
21.3.3 Terumo Corporation Pipeline Products by Therapy Area 176
21.3.4 Terumo Corporation Pipeline Products by Clinical Trials 177
21.3.5 Terumo Corporation Pipeline Products by News Summary 177
22 Appendix 178
22.1 Global Markets Direct Research Methodology 178
22.2 Coverage 179
22.3 Secondary Research 179
22.4 Primary Research 180
22.5 Models 180
22.6 Forecasts 181
22.7 Expert Panels 181
22.8 Currency Conversion 182
22.9 Contact Us 183
22.10 Disclaimer 183

Executive Summary

1.2 List of Figures
Figure 1: Cardiovascular Devices Cross Country Comparison (2000-2012) 29
Figure 2: Cardiovascular Devices, Egypt, Overall Revenues ($ mn), 2000-2012 30
Figure 3: Cardiovascular Devices, Egypt, Portfolio Analysis, 2000-2012 31
Figure 4: Cardiovascular Devices, Egypt, Overall Revenues ($ mn), Historic, 2000-2007 32
Figure 5: Cardiovascular Devices, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 34
Figure 6: Cardiovascular Devices, Egypt, Category Volume (Units), 2000-2012 36
Figure 7: Cardiovascular Devices, Egypt, Category Volume (Units), Historic, 2000-2007 37
Figure 8: Cardiovascular Devices, Egypt, Category Volume (Units), Forecast, 2007-2012 39
Figure 9: Cardiovascular Devices, Egypt, Company Share (%), 2007 41
Figure 10: Cardiac Rhythm Management, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 42
Figure 11: Cardiac Rhythm Management, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 43
Figure 12: Cardiac Resynchronisation Therapy, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 44
Figure 13: Cardiac Resynchronisation Therapy, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 45
Figure 14: Implantable Cardioverter Defibrillator, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 46
Figure 15: Implantable Cardioverter Defibrillator, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 47
Figure 16: Pacemaker, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 48
Figure 17: Pacemaker, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 49
Figure 18: Cardiac Rhythm Management, Egypt, Overall Volume (Units), Historic, 2000-2007 50
Figure 19: Cardiac Rhythm Management, Egypt, Overall Volume (Units), Forecast, 2007-2012 51
Figure 20: Cardiac Resynchronisation Therapy, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 52
Figure 21: Cardiac Resynchronisation Therapy, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 53
Figure 22: Implantable Cardioverter Defibrillator, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 54
Figure 23: Implantable Cardioverter Defibrillator, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 55
Figure 24: Pacemaker, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 56
Figure 25: Pacemaker, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 57
Figure 26: Cardiac Rhythm Management, Egypt, Company Share (%), 2007 60
Figure 27: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 61
Figure 28: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 63
Figure 29: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Overall Volume (Units), Historic, 2000-2007 65
Figure 30: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Overall Volume (Units), Forecast, 2007-2012 66
Figure 31: Cardiovascular Monitoring and Diagnostic Devices, Egypt, Company Share (%), 2007 69
Figure 32: Cardiovascular Prosthetic Devices, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 70
Figure 33: Cardiovascular Prosthetic Devices, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 72
Figure 34: Cardiac Assist Devices, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 73
Figure 35: Cardiac Assist Devices, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 74
Figure 36: Prosthetic Heart Valve, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 75
Figure 37: Prosthetic Heart Valve, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 76
Figure 38: Cardiovascular Prosthetic Devices, Egypt, Overall Volume (Units), Historic, 2000-2007 77
Figure 39: Cardiovascular Prosthetic Devices, Egypt, Overall Volume (Units), Forecast, 2007-2012 78
Figure 40: Cardiac Assist Devices, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 79
Figure 41: Cardiac Assist Devices, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 80
Figure 42: Prosthetic Heart Valve, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 81
Figure 43: Prosthetic Heart Valve, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 82
Figure 44: Cardiovascular Prosthetic Devices, Egypt, Company Share (%), 2007 85
Figure 45: Cardiovascular Surgery, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 86
Figure 46: Cardiovascular Surgery, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 88
Figure 47: Perfusion Disposables, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 89
Figure 48: Perfusion Disposables, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 90
Figure 49: Perfusion Disposables, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 92
Figure 50: Perfusion Disposables, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 93
Figure 51: Cardiovascular Surgery, Egypt, Company Share (%), 2007 96
Figure 52: Electrophysiology, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 97
Figure 53: Electrophysiology, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 98
Figure 54: Electrophysiology, Egypt, Company Share (%), 2007 102
Figure 55: Interventional Cardiology, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 103
Figure 56: Interventional Cardiology, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 105
Figure 57: Cardiac Catheter, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 107
Figure 58: Cardiac Catheter, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 108
Figure 59: Coronary Stent, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 109
Figure 60: Coronary Stent, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 110
Figure 61: PTCA Balloon, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 111
Figure 62: PTCA Balloon, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 112
Figure 63: Interventional Cardiology, Egypt, Overall Volume (Units), Historic, 2000-2007 113
Figure 64: Interventional Cardiology, Egypt, Overall Volume (Units), Forecast, 2007-2012 115
Figure 65: Cardiac Catheter, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 117
Figure 66: Cardiac Catheter, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 118
Figure 67: Coronary Stent, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 119
Figure 68: Coronary Stent, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 120
Figure 69: PTCA Balloon, Egypt, Volume (Units) by Sub-Segment, Historic, 2000-2007 121
Figure 70: PTCA Balloon, Egypt, Volume (Units) by Sub-Segment, Forecast, 2007-2012 122
Figure 71: Interventional Cardiology, Egypt, Company Share (%), 2007 126
Figure 72: Peripheral Vascular Devices, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 127
Figure 73: Peripheral Vascular Devices, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 129
Figure 74: Peripheral Vascular Devices, Egypt, Overall Volume (Units), Historic, 2000-2007 131
Figure 75: Peripheral Vascular Devices, Egypt, Overall Volume (Units), Forecast, 2007-2012 133
Figure 76: Peripheral Vascular Devices, Egypt, Company Share (%), 2007 137
Figure 77: Medtronic, Inc. Value Chain Analysis 139
Figure 78: Boston Scientific Corporation Value Chain Analysis 149
Figure 79: St. Jude Medical Inc. Value Chain Analysis 162
Figure 80: Abbott Laboratories Value Chain Analysis 170
Figure 81: Terumo Corporation Value Chain Analysis 174
Figure 82: Global Markets Direct Methodology 178

Medtronic, Inc.
Boston Scientific Corporation
Cordis Corporation
St. Jude Medical Inc.
Abbott Laboratories
Terumo Corporation

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos